Skip to main content
SpringerLink
Log in

Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis

  • Original Article
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Objective

To conduct a meta-analysis of studies assessing abnormal glucose metabolism (AGM) prevalence among patients with primary aldosteronism (PA), calculating a combined pooled prevalence and summarizing metabolic parameters associated the pooled prevalence for comparative group.

Method

Four electronic databases (PubMed, EMBASE, Cochrane CENTRAL, and ISI-Web of Science) were systematically retrieved with no language and time restriction. Studies about elevated level of glucose metabolism in primary aldosteronism were included.

Result

Data were available in 16 studies. The pooled analysis revealed that the prevalence of elevated glucose in PA was 22.41 % (95 % CI 16.77–28.05 %), the retrospectively calculated prevalence was 31.20 % (95 % CI 15.81–46.60 %) for impaired fasting glucose, 26.19 % (95 % CI 15.17–37.21 %) for impaired glucose tolerance, 15.22 % (95 % CI 9.93–20.51 %) for diabetes mellitus. Prevalence of AGM in PA was higher than that in essential hypertension (OR = 1.55, 95 % CI 1.01–2.36, p = 0.04). From comparative groups, patients with primary aldosteronism had a lower level of insulin sensitivity indicators in comparison with normal group (p < 0.01). On the other hand, insulin resistance which presented by HOMA index was stronger in PA group than in normal control group (WMD = 0.41, 95 % CI 0.17, 0.65; p = 0.001), whereas it was weaker than that in EH group (WMD = −0.37, 95 % CI −0.62, −0.13; p = 0.003).

Conclusion

There is a significant prevalence of elevated level of glucose metabolism in patients with PA. Awareness and treatment of this pre-diabetic or diabetic state are necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Conn JW (1965) Hypertension, the potassium ion and impaired carbohydrate tolerance. N Engl J Med 273(21):1135–1143

    Article  PubMed  CAS  Google Scholar 

  2. Fallo F, Veglio F, Bertello C et al (2006) Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 91(2):454–459

    Article  PubMed  CAS  Google Scholar 

  3. Connell JM, MacKenzie SM, Freel EM et al (2008) A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev 29(2):133–154

    Article  PubMed  CAS  Google Scholar 

  4. Quinkler M, Born-Frontsberg E, Fourkiotis VG (2010) Comorbidities in primary aldosteronism. Horm Metab Res 42(6):429–434

    Article  PubMed  CAS  Google Scholar 

  5. Strauch B, Widimsky J, Sindelka G et al (2003) Does the treatment of primary hyperaldosteronism influence glucose tolerance? Physiol Res 52(4):503–506

    PubMed  CAS  Google Scholar 

  6. Colussi G, Catena C, Lapenna R et al (2007) Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients. Diabetes Care 30(9):2349–2354

    Article  PubMed  CAS  Google Scholar 

  7. Giacchetti G, Ronconi V, Turchi F et al (2007) Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J Hypertens 25(1):177–186

    Article  PubMed  CAS  Google Scholar 

  8. Kreze AS, Kreze-Spirova E, Mikulecky M (2000) Diabetes mellitus in primary aldosteronism. Bratisl Lek Listy 101(4):187–190

    PubMed  Google Scholar 

  9. Choi CS, Thompson CB, Leong PK et al (2001) Short-term K(+) deprivation provokes insulin resistance of cellular K(+) uptake revealed with the K(+) clamp. Am J Physiol Renal Physiol 280(1):F95–F102

    PubMed  CAS  Google Scholar 

  10. Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283(15):2008–2012

    Article  PubMed  CAS  Google Scholar 

  11. Singer S, Das-Munshi J, Brahler E (2010) Prevalence of mental health conditions in cancer patients in acute care–a meta-analysis. Ann Oncol 21(5):925–930

    Article  PubMed  CAS  Google Scholar 

  12. Biddle DA, Morris SB (2011) Using Lancaster’s mid-P correction to the Fisher’s exact test for adverse impact analyses. J Appl Psychol 96(5):956–965

    Article  PubMed  Google Scholar 

  13. Lydersen S, Laake P (2003) Power comparison of two-sided exact tests for association in 2 × 2 contingency tables using standard, mid p and randomized test versions. Stat Med 22(24):3859–3871

    Article  PubMed  Google Scholar 

  14. Brown L, Cai T, DasGupta A (2001) Interval estimation for a binomial proportion. Stat Sci 16:101–117

    Google Scholar 

  15. Higgins JP, Green S, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, in http://www.cochrane-handbook.org/

  16. Egger M, Davey Smith G, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  17. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101

    Article  PubMed  CAS  Google Scholar 

  18. Catena C, Lapenna R, Baroselli S et al (2006) Insulin sensitivity in patients with primary aldosteronism: a follow-up study. J Clin Endocrinol Metab 91(9):3457–3463

    Article  PubMed  CAS  Google Scholar 

  19. Fallo F, Della Mea P, Sonino N et al (2007) Adiponectin and insulin sensitivity in primary aldosteronism. Am J Hypertens 20(8):855–861

    Article  PubMed  CAS  Google Scholar 

  20. Haluzik M, Sindelka G, Widimsky J Jr et al (2002) Serum leptin levels in patients with primary hyperaldosteronism before and after treatment: relationships to insulin sensitivity. J Hum Hypertens 16(1):41–45

    Article  PubMed  CAS  Google Scholar 

  21. Iacobellis G, Petramala L, Cotesta D et al (2010) Adipokines and cardiometabolic profile in primary hyperaldosteronism. J Clin Endocrinol Metab 95(5):2391–2398

    Article  PubMed  CAS  Google Scholar 

  22. Ishimori M, Takeda N, Okumura S et al (1994) Increased insulin sensitivity in patients with aldosterone producing adenoma. Clin Endocrinol (Oxf) 41(4):433–438

    Article  CAS  Google Scholar 

  23. Matrozova J, Steichen O, Amar L et al (2009) Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study. Hypertension 53(4):605–610

    Article  PubMed  CAS  Google Scholar 

  24. Mosso LM, Carvajal CA, Maiz A et al (2007) A possible association between primary aldosteronism and a lower beta-cell function. J Hypertens 25(10):2125–2130

    Article  PubMed  CAS  Google Scholar 

  25. Reincke M, Meisinger C, Holle R et al (2010) Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn’s Registry. Horm Metab Res 42(6):435–439

    Article  PubMed  CAS  Google Scholar 

  26. Widimsky J Jr, Sindelka G, Haas T et al (2000) Impaired insulin action in primary hyperaldosteronism. Physiol Res 49(2):241–244

    PubMed  CAS  Google Scholar 

  27. Widimsky J Jr, Strauch B, Sindelka G et al (2001) Can primary hyperaldosteronism be considered as a specific form of diabetes mellitus? Physiol Res 50(6):603–607

    PubMed  Google Scholar 

  28. Sindelka G, Widimsky J, Haas T et al (2000) Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment. Exp Clin Endocrinol Diabet 108(1):21–25

    CAS  Google Scholar 

  29. Fischer E, Adolf C, Pallauf A et al. (2013) Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. J Clin Endocrin Metab 98(6):2513–2520

    Google Scholar 

  30. Nanba K, Tamanaha T, Nakao K et al (2012) Confirmatory testing in primary aldosteronism. J Clin Endocrinol Metab 97(5):1688–1694

    Article  PubMed  CAS  Google Scholar 

  31. Reungjui S, Pratipanawatr T, Johnson RJ et al (2008) Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia. Curr Opin Nephrol Hypertens 17(5):470–476

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  32. Yokoshiki H, Sunagawa M, Seki T et al (1998) ATP-sensitive K + channels in pancreatic, cardiac, and vascular smooth muscle cells. Am J Physiol 274(1 Pt 1):C25–C37

    PubMed  CAS  Google Scholar 

  33. Fallo F, Pilon C, Urbanet R (2012) Primary aldosteronism and metabolic syndrome. Horm Metab Res 44(3):208–214

    Article  PubMed  CAS  Google Scholar 

  34. Underwood PC, Adler GK (2013) The renin angiotensin aldosterone system and insulin resistance in humans. Curr Hypertens Rep 15(1):59–70

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  35. Vaidya A, Underwood PC, Hopkins PN et al (2013) Abnormal aldosterone physiology and cardiometabolic risk factors. Hypertension 61(4):886–893

    Article  PubMed Central  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None declared.

Author information

Authors and Affiliations

  1. Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China

    W. Chen, F. Li, C. He, Y. Zhu & W. Tan

Authors
  1. W. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. He
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y. Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. W. Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. Tan.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 61 kb)

Supplementary material 2 (DOC 81 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chen, W., Li, F., He, C. et al. Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis. Ir J Med Sci 183, 283–291 (2014). https://doi.org/10.1007/s11845-013-1007-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-013-1007-x

Keywords

Search

Navigation